Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 39 h ago

Emergent BioSolutions Inc.: AMERICAN CENTURY INVESTMENT MANAGEMENT INC amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

American Century Investment Management Inc. amended its Schedule 13G stake filing for Emergent BioSolutions Inc., disclosing a change in its beneficial ownership position under SEC accession 0000052388-26-000425. The filing updates the investment manager's passive stake in the biopharmaceutical company, though the amended document did not specify the exact size of the position or the direction of the change. Schedule 13G amendments are typically filed when a holder's ownership crosses the 5% threshold or when a previously reported position changes materially. Investors will watch for further detail on American Century's holdings and any subsequent 13G or 13D filings that clarify whether the adjustment reflects accumulation or reduction. Emergent BioSolutions shares remain sensitive to institutional ownership shifts given the company's contract-driven revenue base.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Emergent BioSolutions Inc., American Century Investment Management Inc